Cargando…
Upregulation of ECT2 is associated with transcriptional program of cancer stem cells and predicts poor clinical outcome in gastric cancer
Gastric cancer remains the third leading cause of cancer-associated mortality worldwide. The identification of prognostic indicators that are associated with clinical characteristics is urgently required. The aim of the present study was to determine the involvement of epithelial cell transforming 2...
Autores principales: | Gong, Dao-Yin, Chen, Xian, Yang, Tian-Lin, Wang, Yi, Guo, Yu, Zeng, Jin-Hao, Chen, Shan-Ze |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416382/ https://www.ncbi.nlm.nih.gov/pubmed/32788941 http://dx.doi.org/10.3892/ol.2020.11915 |
Ejemplares similares
-
Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients
por: Zhang, Hua, et al.
Publicado: (2021) -
Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2021) -
Increased expression of ECT2 predicts the poor prognosis of breast cancer patients
por: Yi, Ming, et al.
Publicado: (2022) -
Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis
por: Wu, Ping, et al.
Publicado: (2020) -
Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer
por: Xiu, Yingying, et al.
Publicado: (2019)